Publicly available records indicate that a class action lawsuit has been filed on behalf of investors in Insys Therapeutics (NASDAQ:INSY) in connection to alleged violations of securities laws by INSY and certain of its officers. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in Insys Therapeutics between February 23,…

Read More